China Pulled 359 Drugs From Market For Illegal Ads In 2007
This article was originally published in PharmAsia News
Executive Summary
A total of 359 drugs were kept off the market by Chinese authorities in the first 10 months of last year because of advertisements deemed illegal. The State FDA said it counted 50,823 illegal ads for medical products during a time when it approved only 16,365. Of the ones approved, it had to recall 122 for various violations such as false or exaggerated assertions. May 2007 was the effective date for a new Measures for the Examination of Drug Advertisements, which allowed government agencies to take action against drug makers for illegal ads. (Click here for more
You may also be interested in...
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.